Several investigators have shown that CD44+/CD24− cell staining is not an entirely consistent indicator of tumor initiating ability in ER−/PR−/Her2− breast cancer cells due to over-staining of TNBCs [23, 48–51]. Here, CD44 is linked to breast carcinoma.